•
Oct 31, 2024
Oct 30, 2024
Oct 25, 2024
OPGEN INC [OPGN] has reported fiscal Q1 loss of $5.70 million.
On a per-share basis, the DE based company said its diluted earnings are $1.25.
The Medical Laboratories firm posted revenue of $913.40 million in this period.
Also Read: OpGen Reports First Quarter 2023 Financial Results and Provides Business UpdateOpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th ...OpGen Announces Closing of $3.5 Million Public OfferingOpGen Announces Pricing of $3.5 Million Public OfferingOpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND